- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 98,450 | 16.08.24 17:35:40 | +0,470 | +0,48% | 0,000 | 0,000 | 98,350 | 98,450 |
|
Regeneron Pharmaceuticals | 881535 | NASDAQ | 1.179,310 | 16.08.24 22:15:00 | +3,980 | +0,34% | 1.179,170 | 1.889,560 | 1.175,000 | 1.179,310 |
